Evofem Biosciences EVFM Stock Price can get back to $8? URGENT Report
Evofem Biosciences EVFM Stock Price has been trying to recover since the beginning of the summer. It has started to bounce but can it make a full recovery to the YTD high of $8.00.
That would be a gain of 700%++!
Wondering why this stock is having such a hard time and if it can break the overall trend? Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!
[thrive_leads id=’14274′]
Before we get started, I wanted to introduce myself to you. Hi 🙋♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.
I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.
What do I mean by big winners?
Stocks that move more than 100% in a month! EVFM Stock Price could?
Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!
The article is HERE where I shine a spotlight on trending stocks and breakout stocks!
Now, let’s go over some of the basic information on this stock before we get in the technical analysis
Evofem Biosciences Inc. Company Information
Company Name: Evofem Biosciences
Ticker: EVFM
Exchange: NASDAQ
Website: https://www.evofem.com/
Evofem Biosciences Inc. Company Summary:
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women’s sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
EVFM stock price is due to News?
Jun 28, 2022 (PRNewswire via COMTEX) — PR Newswire
SAN DIEGO, June 28, 2022
- Agreement Significantly Expands Access to Phexxi(R) for Millions of Women Seeking an FDA-Approved, Hormone-Free, On-Demand Option to Prevent Pregnancy
- Long-term Contract Adds to Growing List of Agreements with Payers Opening New and Significant Access to Phexxi
- Evofem Expects Increases in Phexxi Prescriptions and Significant Cost-Savings from Agreements
EVFM 5 Day Chart
EVFM Stock Price Technical Analysis:
I love this stock! If you want to be cautious wait for it to pass the resistance point at$1.15.
[thrive_leads id=’14274′]